{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:44:59Z","timestamp":1792759499550,"version":"4.5.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.36687","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T01:40:55Z","timestamp":1613180455000},"page":"e2036687","source":"Crossref","is-referenced-by-count":168,"title":["Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018"],"prefix":"10.1001","volume":"4","author":[{"given":"Byungkyu","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Sociology, Indiana University-Bloomington, Bloomington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Luddy School of Informatics, Computing, and Engineering, Indiana University-Bloomington, Bloomington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Cheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Luddy School of Informatics, Computing, and Engineering, Indiana University-Bloomington, Bloomington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Yeol","family":"Ahn","sequence":"additional","affiliation":[{"name":"Luddy School of Informatics, Computing, and Engineering, Indiana University-Bloomington, Bloomington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brea L.","family":"Perry","sequence":"additional","affiliation":[{"name":"Network Science Institute, Department of Sociology, Indiana University-Bloomington, Bloomington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"issue":"2","key":"zoi201097r1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use.","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi201097r2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants.","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am J Public Health"},{"key":"zoi201097r4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugalcdep.2017.12.002","article-title":"Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.","volume":"184","author":"Pauly","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi201097r5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMsa1514387","article-title":"State legal restrictions and prescription-opioid use among disabled adults.","volume":"375","author":"Meara","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi201097r6","first-page":"297","article-title":"State prescription drug monitoring programs and fatal drug overdoses.","volume":"23","author":"Nam","year":"2017","journal-title":"Am J Manag Care"},{"issue":"5","key":"zoi201097r7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose.","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med"},{"issue":"1","key":"zoi201097r8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1257\/pol.20160094","article-title":"The effect of prescription drug monitoring programs on opioid utilization in Medicare.","volume":"10","author":"Buchmueller","year":"2018","journal-title":"Am Econ J Econ Policy"},{"issue":"4","key":"zoi201097r9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1162\/ajhe_a_00101","article-title":"Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse.","volume":"4","author":"Meinhofer","year":"2018","journal-title":"Am J Health Econ"},{"issue":"6","key":"zoi201097r10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jamainternmed.2019.0272","article-title":"Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose.","volume":"179","author":"Abouk","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi201097r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/700703","article-title":"With a little help from my friends: the effects of good Samaritan and naloxone access laws on opioid-related deaths.","volume":"62","author":"Rees","year":"2019","journal-title":"J Law Econ"},{"issue":"11","key":"zoi201097r13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review.","volume":"168","author":"Fink","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi201097r14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the impact of prescription drug monitoring program implementation: a scoping review.","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"zoi201097r18","doi-asserted-by":"publisher","first-page":"l6968","DOI":"10.1136\/bmj.l6968","article-title":"Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study.","volume":"368","author":"Kiang","year":"2020","journal-title":"BMJ"},{"issue":"10","key":"zoi201097r19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223849","article-title":"Co-prescription network reveals social dynamics of opioid doctor shopping.","volume":"14","author":"Perry","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"zoi201097r20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system.","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"15","key":"zoi201097r21","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"zoi201097r22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/pds.v19:2","article-title":"Usefulness of prescription monitoring programs for surveillance\u2014analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006.","volume":"19","author":"Katz","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"zoi201097r23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"zoi201097r24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2018.06.039","article-title":"Polydrug use among heroin users in Cleveland, OH.","volume":"192","author":"Bobashev","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"26","key":"zoi201097r25","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002-2013.","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"zoi201097r27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package.","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"3","key":"zoi201097r28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States.","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"issue":"6408","key":"zoi201097r29","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"issue":"10117","key":"zoi201097r30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(18)30057-6","article-title":"A public health approach to opioid addiction in North America.","volume":"391","author":"Karamouzian","year":"2018","journal-title":"Lancet"},{"key":"zoi201097r33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2015.12.025","article-title":"Effect of a \u201cpill mill\u201d law on opioid prescribing and utilization: the case of Texas.","volume":"159","author":"Lyapustina","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"zoi201097r34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida\u2019s prescription drug monitoring program and pill mill laws on opioid prescribing and use.","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"6","key":"zoi201097r36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6215","article-title":"Association of naloxone coprescription laws with naloxone prescription dispensing in the United States.","volume":"2","author":"Sohn","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi201097r37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3209","article-title":"Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose.","volume":"2","author":"Follman","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi201097r38","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1111\/add.v114.11","article-title":"Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.","volume":"114","author":"Swartz","year":"2019","journal-title":"Addiction"},{"issue":"5","key":"zoi201097r39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jamainternmed.2020.0473","article-title":"Association between Medicaid expansion and rates of opioid-related hospital use.","volume":"180","author":"Wen","year":"2020","journal-title":"JAMA Intern Med"},{"key":"zoi201097r40","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1111\/j.1526-4637.2011.01132.x","article-title":"Obtaining adequate data to determine causes of opioid-related overdose deaths.","volume":"12","author":"Webster","year":"2011","journal-title":"Pain Med"},{"issue":"11","key":"zoi201097r41","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/MLR.0000000000000805","article-title":"Trends in opioid-related inpatient stays shifted after the US transitioned to ICD-10-CM diagnosis coding in 2015.","volume":"55","author":"Heslin","year":"2017","journal-title":"Med Care"},{"issue":"10182","key":"zoi201097r42","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions.","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"zoi201097r43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1257\/pol.20170082","article-title":"Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterrent opioids.","volume":"10","author":"Alpert","year":"2018","journal-title":"Am Econ J Econ Policy"},{"key":"zoi201097r3","doi-asserted-by":"crossref","unstructured":"Mallatt? J. The effect of prescription drug monitoring programs on opioid prescriptions and heroin crime rates.? SSRN. Preprint posted online September 13, 2018. doi:10.2139\/ssrn.3050692","DOI":"10.2139\/ssrn.3050692"},{"key":"zoi201097r11","doi-asserted-by":"crossref","unstructured":"Doleac? JL, Mukherjee? A. The moral hazard of lifesaving innovations: naloxone access, opioid abuse, and crime.? SSRN. Preprint posted online March 31, 2019. doi:10.2139\/ssrn.3135264","DOI":"10.2139\/ssrn.3135264"},{"key":"zoi201097r15","unstructured":"Horwitz? J, Davis? C, McClelland? L, Fordon? R, Meara? E. The problem of data quality in analyses of opioid regulation: the case of prescription drug monitoring programs. National Bureau of Economic Research working paper 2494. Accessed January 6, 2020. https:\/\/www.nber.org\/system\/files\/working_papers\/w24947\/w24947.pdf"},{"key":"zoi201097r16","unstructured":"Goodman-Bacon? A. Difference-in-differences with variation in treatment timing. National Bureau of Economic Research working paper 25018. Accessed January 6, 2020. https:\/\/www.nber.org\/system\/files\/working_papers\/w25018\/w25018.pdf"},{"key":"zoi201097r17","doi-asserted-by":"crossref","unstructured":"Imai? K, Kim? IS. On the use of two-way fixed effects regression models for causal inference with panel data. Accessed January 6, 2020. https:\/\/imai.fas.harvard.edu\/research\/twoway.html","DOI":"10.1017\/pan.2020.33"},{"key":"zoi201097r26","doi-asserted-by":"crossref","unstructured":"Imai? K, Kim? IS, Wang? E. Matching methods for causal inference with time-series cross-sectional data. Accessed January 6, 2020. https:\/\/imai.fas.harvard.edu\/research\/files\/tscs.pdf","DOI":"10.1111\/ajps.12685"},{"key":"zoi201097r31","unstructured":"Dave? D, Grecu? A, Saffer? H. Mandatory access prescription drug monitoring programs and prescription drug abuse. National Bureau of Economic Research working paper 23537. Accessed January 6, 2020. https:\/\/www.nber.org\/system\/files\/working_papers\/w23537\/w23537.pdf"},{"key":"zoi201097r32","doi-asserted-by":"crossref","unstructured":"Sacks? DW, Hollingsworth? A, Nguyen? TD, Simon? KI. Can policy affect initiation of addictive substance use? evidence from opioid prescribing? evidence from opioid prescribing. National Bureau of Economic Research working paper 25974. June 2019. Accessed January 6, 2020. https:\/\/www.nber.org\/system\/files\/working_papers\/w25974\/w25974.pdf","DOI":"10.3386\/w25974"},{"key":"zoi201097r35","doi-asserted-by":"crossref","unstructured":"Pohl? RV. Time trends matter: the case of medical cannabis laws and opioid overdose mortality.? SSRN. Preprint posted online November 21, 2019.","DOI":"10.2139\/ssrn.3192703"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776301\/lee_2021_oi_201097_1615224939.27128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:11:11Z","timestamp":1671250271000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.36687","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}